Articles tagged with "Rheumatoid Arthritis (RA)"

FDA Approves Upadacitinib for RA

September 2, 2019 • By Michele B. Kaufman, PharmD, BCGP

Long-Term Physical Activity Lowers the Risk of RA among Women

August 27, 2019 • By Arthritis & Rheumatology

Filgotinib Promising for RA

August 26, 2019 • By Michele B. Kaufman, PharmD, BCGP

FDA Approves AbbVie’s New Rheumatoid Arthritis Drug

August 19, 2019 • By Reuters Staff

Otilimab Begins Phase 3 Clinical Studies for RA

August 19, 2019 • By Michele B. Kaufman, PharmD, BCGP

ACR Prepares to Submit Rheumatoid Arthritis Alternative Payment Model

August 16, 2019 • By From the College

Asthma, Allergic Disease, Passive Smoke Exposure & the Risk of RA

August 7, 2019 • By Arthritis & Rheumatology

Baricitinib: Early vs. Late Treatment Outcomes in RA Patients

August 5, 2019 • By Michele B. Kaufman, PharmD, BCGP

A More Complicated Pregnancy: Inflammatory Arthritis Increases the Risk for Adverse Outcomes

August 2, 2019

RheumPAC Advocates for Department of Defense Arthritis Research Funding

August 1, 2019 • By Matt Baker, MD, MS